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Forms of selective autophagy have now been recognized to regulate flux in many intracellular processes.
Specific pathways and functions have been identified for mitophagy, ERphagy, and other selective
autophagies; yet there is no consensus in whether and how autophagy regulates protein maintenance in
and around the nucleus. Such processes are of interest for potential degradation of DNA and nuclear
envelope proteins in various disease states. The mechanistic details of such nucleus-related autophagic
processes remain elusive due to the lack of chemical or genetic regulators to manipulate and follow the
process in vitro. Here, we describe a high content screen from which we identified small chemical
compounds that can modulate the localization of the autophagy marker MAP1LC3B (LC3) in renal
carcinoma cells. We also describe a pipeline designed for the execution and analysis of high content
screens. The chemical tools discerned from this screen will allow for the deeper exploration of the
mechanism, regulation, and molecular targets of nuclear-localized LC3 in perturbed cellular states.
Design Type(s) screening campaign • compound treatment design • dose response design
Measurement Type(s) subcellular morphology • dose response curve
Technology Type(s) high content screening
Factor Type(s) chemical entity • biological replicate
Sample Characteristic(s) RCC 786-O cell
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Background & Summary
Autophagy is a conserved membrane trafficking process that degrades cellular materials to enhance
survival1. This process was originally seen as a non-selective mechanism activated by general cellular
stress such as nutrient deprivation. Recent research has shown, however, that autophagy is additionally
responsible for cellular maintenance through the selective degradation of material within specific
organelles, including the ER, mitochondria, peroxisomes, and nuclei2. Some forms of selective autophagy,
such as mitophagy and ER-phagy2,3 have been well characterized, while nucleus-related autophagy
(nucleophagy) is just becoming recognized. The term nucleophagy may actually represent multiple
unique phenomenon associated with the recycling of DNA, nuclear envelope proteins, other nuclear
material4, micronuclei regulation, or general protein transport dynamics. Autophagy is regularly tracked
by LC3 (ATG8, officially MAP1LC3), a microtubule associated protein required for assembly and
transport of autophagosomes5. LC3B, along with the other autophagy-related isoforms (LC3A, LC3C) are
commonly found in and around the nucleus6. Here, we perform a high content screen to discover novel
chemical tools that specifically modulate nuclear localization of LC3B in a cancer cell line.
In mammalian cells, the process of nucleophagy likely involves the formation of intra- or juxtanuclear
autophagosomes containing LC3, nuclear envelope components, and/or DNA which subsequently enter
the macroautophagy pathway and fuse with lysosomes7 (for review of macroautophagy, see refs 8,9). In
disease settings, newly transformed cells upregulate nucleophagy to trigger senescence-induced nuclear
envelope remodeling and thereby protect against cancer development4. Nucleophagy may also be
involved in the nuclear envelope disintegration and recovery during cancer cell migration4,10. Similarly,
envelopathies, laminopathies, and some neurodegenerative diseases (i.e. Huntington’s) may arise from
nucleophagy defects11–13.
Other forms of nucleophagy include the engulfment of micronuclei by an autophagosome, or
extraction of intranuclear material that may not include the envelope14. In the context of amyotrophic
lateral sclerosis (ALS), C9orf72 mutations cause the buildup of toxic antisense RNA foci within the
nucleus15. Nucleophagy is a mechanism for the disposal of these RNA stress granules16, and may be
important during the onset and progression of disease.
High content screening (HCS) is an automated, microscope-based method used here to discern small
compounds that directionally alter the prevalence of cellular phenotypes. We implemented HCS to
monitor the effects of small molecules on nuclear morphology and LC3 localization. High content screens
are typically coupled with analysis (sometimes termed HCA) to allow for the simultaneous execution and
integration of several experiments17. Though powerful and widely implemented18, HCS is generally
difficult and expensive for labs with limited resources.
We adapt several HCS techniques to more standard laboratory equipment and analysis packages then
identify a set of small-molecule nuclear LC3 localization modulators. Identified compounds may
contribute to the understanding of LC3 nuclear-cytoplasmic transport and nucleophagy in various
disease states. On a broader scale, this screen can serve as a template of a widely-accessible microscopy-
based pipeline for medium throughput, high content screening in a number of diverse settings.
Methods
Cell Culture
786-0 (CRL1932) human cancer cell line from ATCC (Manassas, VA) was cultured in Dulbecco’s
Modified Eagle Medium (Thermofisher 11995-065) supplemented with 10% Fetal Bovine Serum (FBS)
(Thermofisher 26140079) and 1% PenStrep (Thermofisher 15140-122). Cells were seeded in a 96-well
plate at a density of 3,000 cells per well in 100 μL media. Cells were allowed to adhere and divide in a
humidified incubator at 37 °C and 5% CO2 for 24 h prior to treatment.
High Content Chemical Screening Assay
1,539 chemical compounds from the NCI DTP diversity set IV were used to identify tools that specifically
modulate LC3 localization. Prior to the in vitro experiments, the screening compounds were diluted in
dimethyl sulfoxide (DMSO) to stock concentrations of 1000 μM and stored in −80 °C. Immediately
before experiments, the 1000 μM stocks were further diluted to 80 μM in a 10% DMSO and 90%
Phosphate Buffered Saline (PBS) solution, which was used to balance solubility with toxicity of DMSO.
786-0 cells were cultured in a 96 well plate and incubated for 24 h at 37 °C. The border wells of the plate
were exposed to a vehicle (DMSO or PBS) and the middle wells to a particular library compound at 8.89
μM. After 4 h of incubation at 37 °C, media was replaced and cells were incubated an additional 18 h
before being fixed and stained. Each screening compound was tested in 2-4 independent replicates
(different passages of cells from separate days).
Immunofluorescence staining
Expression Analysis. In the screen, LC3B localization was tracked in each cell. To determine the most
commonly expressed isoforms, we analysed a publicly available microarray dataset comparing LC3A,
LC3B, and LC3C expression across the NCI-60 cell lines [Data Citation 1]. Each cell line had three
replicates. The cell lines were ranked (low to high) by log transformed expression values for each isoform
of LC3 (Supplementary Table 1). Compared to the other cancer lines, 786-0 cells express a standard
amount of both LC3B and LC3C but has less LC3A than other cancer cell lines. In addition to having
www.nature.com/sdata/
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LC3B expression comparable with most other NCI-60 cancer cells, 786-0 has 4.7 times more LC3B
expression than LC3C, making LC3B the dominant isoform.
Epitope Analysis. LC3B/MAP1LC3B primary antibody (ThermoFisher, L10382) is more specific to the
human LC3B protein than closely related isoforms (MAP1)LC3A and (MAP1)LC3C. The LC3B epitope
sequence (PSEKTFKQRRTFEQ) recognized by the antibody was compared against LC3A and LC3C
protein sequences below.
LC3A PSDRPFKQRRSFAD
LC3B PSEKTFKQRRTFEQ
LC3C PSVRPFKQRKSLAI
The bold amino acids indicate unique regions of sequences. While shared regions do exist, there are
two distinct linear regions that are unique to each individual isoform.
Staining Preparation. 786-0 cells were fixed with 3.2% paraformaldehyde (ThermoFisher) in PBS.
After rinsing three times with PBS, a solution of 1:1 Bovine Serum Albumin (BSA) to PBS and 0.1%
Triton X-100 was added to the plates and incubated at room temperature for one hour to block
and permeabilize the cells. LC3 localization was monitored by staining endogenous LC3B with a LC3B/
MAP1LC3B primary antibody (ThermoFisher, L10382) at a 1:500 dilution and incubating for 72 h at
4 °C. Subsequently, the primary antibody was rinsed three times with PBS. Goat-Anti-Rabbit IgG Alexa
Fluor 546-tagged secondary antibody (ThermoFisher, A-11035) was then added at a 1:1250 dilution and
with the nuclear DNA stain with Hoechst (ThermoFisher, H3570) at a 1:5000 dilution. The plates were
left at room temperature for one hour, rinsed three times with PBS, and later imaged.
Microscopy
Experiments were visualized via a Nikon inverted epifluorescent microscope (40X objective) controlled
by NIS Elements software in a semi-automated fashion. Prior to imaging, a custom pattern of coordinates
was used to move the stage to the center of each well in the 96-well plate. The pattern began at the top left
well of the plate and proceeded down the odd columns and up the even columns. After the user manually
refined the focus of the Hoechst image, a 2x2 montage was captured around the center point. The
Hoechst image was exposed for 400 milliseconds and the LC3 image (with a TRITC filter) for 800
milliseconds. 16-bit, single-channel images were exported from the NIS Elements program as tiff files and
subsequently used for image analysis.
Image Analysis
Object Identification. The stitched 2x2 montage images were run through an ImageJ script, where
each image was split into four individual images19. The open-source software CellProfiler was used to
achieve cell based segmentation by processing individual images containing DNA and LC3 channels20.
Individual nuclei were traced via Mixture of Gaussians (MoG) thresholding with a cytoplasmic area
defined as a set radius of pixels from the nuclear border. The hierarchy of the data is represented in Fig.
1a-d. Intensity, localization, and prevalence of LC3 and DNA were analyzed within the cytoplasm and the
nucleus. Additionally, nuclear area and nuclear holes (defined as areas of low DNA content within the
nucleus) were measured.
Quality Control. Merged RGB jpeg images were exported for visual quality control within TIBCO
Spotfire. Researchers were blind to all experimental conditions during this phase of quality control.
Quality control in Spotfire DecisionSite (TIBCO Spotfire) was achieved by manual examination of each
individual image for possible errors in acquisition, tracing of the cells, nuclei, and nuclear holes. In
addition to manual vetting of images, we checked for images with low measures of image sharpness
(quality), which usually meant the focus was poor. Ultimately, images containing errors in focus, tracing,
low viability of 2 cells or less (indicating toxicity), or other artifacts (such as a lint fragment or dye
precipitate) were omitted from further analysis.
Normalization and Analysis. To adequately compare cells on different plates, data was first
normalized so that the global mean of all the wells within a single assay plate for each data parameter was
equal to 1. This was done simply by dividing by the global mean of the plate for each parameter
separately (implemented with MS Excel). The normalized datasets were then compiled and analyzed.
Each set of replicates were compared side by side to access the reliability of the data. P-values for
significance were extracted from the Spotfire file of the variables of interest. Waterfall plots were
constructed by averaging the mean from the independent replicates, which result from the mean of all the
cells within that replicate well. Those means were ranked and plotted on the x-axis. In the correlation
analysis, replicates were aligned in columns, and MS Excel’s Pearson correlation was used to generate r2
coefficients. Linear regression and ANOVA was performed with Spotfire DecisionSite.
Follow Up Screen
Following the analysis of the initial screen, compounds of interest were selected for follow up dose-
response experiments to confirm their validity and determine optimal dosing. Compounds were selected
www.nature.com/sdata/
SCIENTIFIC DATA | 5:180116 | DOI: 10.1038/sdata.2018.116 3
if they significantly increased or decreased the normalized intensity of nuclear LC3 compared to the
global average. Additional compounds were included that significantly altered nuclear holes and nuclear
area. Compounds of interest were repurchased from the NCI and diluted down to 2000μM in a 10%
DMSO and 90% PBS solution. Cells cultured in 96-well plates were exposed to a serial dilution of the
compounds ranging from 1.25μM to 20μM (based on the original screening dose of 10μM). Plates were
then fixed, stained, and imaged.
Code availability
Three custom code sets can be accessed at (Figshare) [Data Citation 2]. The first (.xml file) can be used
with Nikon NIS Elements AR 3.22 to semi-automatically control the stage and image the 96-well plates.
The second (.ijm file) can be used with ImageJ FIJI 1.47a to split the large tiled images down to single
Figure 1. Assay Hierarchy and Tracing and 1,539-Compound Screening Results. (a–d)
Plate>Well>Field>Cell hierarchy. Cells were ‘traced’ and cytometric data was extracted. The green dashed
lines indicate the “masks” that define the nucleus (internal ring), and cytosol (external ring). The external ring
was created simply by dilating the nuclear mask. The red marks indicate LC3 puncta, which can be localized
either in the cytosol or the nucleus. The number, area, and intensity of LC3 within these puncta are measured.
Additionally, regions of low DNA (marked by the absence of Hoechst dye) are identified as nuclear holes (a gap
in the otherwise blue nucleus). (e–g) Each data point represents one of the 1,304 chemical compounds that
passed quality control. The compounds are ranked by average nuclear LC3 fluorescence (ordered along the
x-axis). The x-axes are the same in each graph. Vertical bars represent standard deviation. The three horizontal
lines in each plot indicate the global mean of the parameter on the y-axis (middle) +/− two standard deviations.
(e) Plot of the average nuclear LC3 intensity. Compounds that were selected for the follow-up screen are
indicated in dark blue (others are in light gray). (f) Ranked compounds plotted against their respective average
cell densities. Points that fell below the mean indicate low cell viability and possible toxicity of the chemical. (g)
Holes per Nuclei (count of nuclear holes). The yellow dashed line in F&G is a curve fit to show the overall
relationship between ranked nuclear LC3 intensity and either cell density or nuclear holes.
www.nature.com/sdata/
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images. The final (.cpproj file) is for CellProfiler 2.2.0, to segment the cells within the image. Other
software used was Spotfire Decision Site 9.1.2 and CorelDraw 15.2.0.
Data Records
All output data from screens is available on FigShare in ZIP files and spreadsheet format titled
“Final_Dataset_Combined” [Data Citation 2].
High Content, Medium Throughput Screening
1,539 chemical compounds from the NCI DTP Diversity Set IV were used to identify molecules that
modulate nuclear LC3 localization. From the 1,304 compounds that passed quality control, further
analyses were conducted to determine effects of these on selected cellular parameters, including
morphology, nuclear and cytosolic intensity of DNA staining, and nuclear and cytosolic intensity of LC3.
Morphological parameters considered include nuclear area, nuclear shape, presence and quantity of LC3
aggregates in nucleus and cytoplasm, and nuclear holes. The majority of compounds had no effect on
nuclear LC3 (shaded markers in Fig. 1e). Many compounds that increased nuclear LC3 decreased cell
viability (diminution of cell density on the left side of Fig. 1f). Compounds that directionally altered
nuclear LC3 slightly increased the abundance of nuclear holes, or areas with low DNA intensity (Fig. 1g),
possibly indicating stress or toxicity.
Though 70 compounds significantly affected at least one of the parameters measured (Po0.001), 34
were selected (marked in blue in Fig. 1e) for follow-up validation screens due to their significant influence
on nuclear and cytoplasmic LC3 intensity as well as abundance of nuclear holes (represented in Fig. 1g).
Compounds that exhibited a significant impact on viability were omitted from the validation screen.
Secondary Screening
Thirty chemical compounds, hereafter referred to as “hits”, were included in a follow-up screen to
validate their effects on the nuclear parameters listed above. Cells were subjected to a dose series of each
compound. Of these 32 hits, the compounds that significantly altered nuclear LC3 localization are
Figure 2. Results from Secondary Screen. The effect of each chemical compound on nuclear LC3 was
quantified using a linear regression (dose vs. nuclear LC3 intensity). The P-value, F-statistic, r2, and degrees of
freedom for the regression are shown in the table. Additionally, the P-value for a linear regression comparing
the dose of the compound to nuclear holes are shown. Bolded P-values were still significant after correcting for
multiple comparisons by Benjamini Hochberg. Red values represent a negative relationship while black values
represent a positive one. Empty cells indicate that a compound did not have significance in this category. The
chemical structure of the top twelve hits is displayed along the sides.
www.nature.com/sdata/
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indicated (Fig. 2) and are potentially useful to study LC3-related phenomena like autophagy and
nucleophagy.
Seventeen compounds were identified as upregulating nuclear LC3 intensity. Only one compound
showed a notable effect on decreasing nuclear LC3 intensity (NSC279895, twelfth row of Fig. 2). After
correcting for multiple comparisons by the Benjamin Hochberg test, 11 of the 17 hits (first 11 rows of
Fig. 2) maintained their significance in increasing nuclear LC3. Since these experiments started with a
high-content screen, we expected many of the initial compounds to be false-positives. We tested the
compounds with the dose series to confirm their legitimacy. Eight of the thirty hits significantly increased
the nuclear holes with dose (NSC60785, NSC126757, NSC279895, NSC236246, NSC135351, NSC319012,
NSC117028 and NSC294154).
Although we are the first to observe the effects of the hits on nuclear LC3 localization, we are not the
first to examine these compounds in a cellular assay. PubChem BioAssays revealed some assay findings
on hits NSC31762 and NSC279895 among others. NSC31762, the compound inducing the strongest
enhancement of nuclear LC3 localization in our screen, has been found active in other cellular assays,
notably TRAIL-induced apoptosis [Data Citation 3]. The TRAIL pathway is an innate-immune death
pathway known to have cross-talk with autophagy and nuclear import/export21,22. NSC279895 [Data
Citation 4], the hit compound shown to reduce nuclear LC3 localization, has been characterized as an
allosteric enhancer of the Human Thyroid Hormone receptor, implicating nuclear translocation23.
Technical Validation
Screening Assay Quality
A technical pre-validation was run before analyzing the primary screen data. We performed a correlation
analysis between replicate plates24. Each treatment was tested for correlation among sets of replicate
plates; with a high r2 indicating the reliability of the drug affecting a particular cellular parameter(s).
Correlation values closer to zero signify noisy data and a lack of consistency between compound effects
for replicates of the same assay plate. Among the source plates used (Fig. 3a), all but two had adequate
correlation. Among the various parameters measured (Fig. 3b), LC3 intensity measurements had
extremely good repeatability, with other measurements being adequate. Covariance analysis provided
insight into the cellular variables that were affected the most by the compound. Cytoplasmic LC3, nuclear
LC3, nuclear area and holes per nuclei were four of the most robust parameters across all plates.
It is common for multi-well plates to suffer from variations in phenotype across the plate (referred to
as plate effects), due to differences in temperature and evaporation, especially comparing the edge wells to
Figure 3. Correlation analysis of plates and parameter. Each pair of plates from the primary screen was
analyzed by direct comparison to its replicate plate or by rotating 180 degrees and comparing. a. Individual
plate IDs are compared well-to-well with their replicate. The displayed value is the average of all the measured
parameters (listed in b), with standard deviation. Blue bars are comparison of like treatments (for example B3
to B3, F5 to F5, making for a high correlation), while red bars are comparison of the treatment to its 180 degree
rotated partner (B3 to G10, F5 to C8). X-axis is ordered so that the plates with the best correlations are on the
left. b. Correlations for measured parameters (ranked best to worst), averaged across all plates.
www.nature.com/sdata/
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the more central wells25. Strong plate effects result in a correlation that is artificially high; sections of the
plate are compared rather than the treatments. To account for this, a second analysis was done after
‘rotating’ one of the two replicate plates 180 degrees, then overlaying it on its complementary replicate
plate (Fig. 3a,b, red bars). As a result, the compounds were no longer aligned and resulting high r2 values
would indicate strong plate effects. From this analysis, we find that most effects observed were due to the
treatment (chemical compound), and not plate effects.
Another technical validation is useful to consider when running compound screens with fluorescent
readouts. Some of the compounds may possess chemical structures that naturally fluorescence at various
wavelengths due to conjugated aromatic rings. It may be useful to assess the chemicals’ optical properties
before using them in vitro to manipulate cellular phenotypes, allowing for the differentiation of probe
intensities from the underlying auto-fluorescence of the chemicals. In this screen, we checked for
compound fluorescence empirically, but that may be avoided by using the third-party analysis program
like Hyperchem to predict the fluorescence spectra of the compounds26.
Usage Notes
The high content, medium throughput screening method described here is a useful alternative to the
established, yet expensive and technically complicated, high throughput process. We utilized free open-
source analysis software packages ImageJ and CellProfiler to analyze functional cellular parameters. We
used our screening pipeline to discern nuclear LC3 localization modulators, however, the applications of
this method extend beyond our results. The pipeline can be implemented for other chemical libraries to
assess the directional influence of a wide array of substances on diverse cellular parameters.
Our screen identifies chemicals that may modulate nuclear-associated types of autophagy. Most forms
of autophagy require the formation of an autophagosome and later fusion of the autophagosome with a
lysosome for degradation of intra-vesicular material. The screening assay here measures nuclear LC3
localization, but it does not test for the autophagic flux into the lysosome.
The novel tools discerned from this screen could be used to understand how nuclear stress and
potentially nucleophagy may alter the cellular phenotype of cells undergoing a variety of stress conditions
in systems beyond cancer. One area of strong interest may be the C9ORF72 mutation implicated in ALS
and FTD, which is known to induce stress-causing RNA foci within the nucleus that may require
clearance by nucleophagy. We hope these chemicals will allow those examining nuclear stress, transport,
and degradation to answer questions about the substrates, receptors, and interacting pathways and their
function involved in these complex processes.
References
1. Murrow, L. & Debnath, J. Autophagy as a stress-response and quality-control mechanism: implications for cell injury and human
disease. Annu. Rev. Pathol 8, 105–137 (2013).
2. Kraft, C., Reggiori, F. & Peter, M. Selective types of autophagy in yeast. Biochimica et Biophysica Acta - Molecular Cell Research
1793, 1404–1412 (2009).
3. Gomes, L. C. & Scorrano, L. Mitochondrial morphology in mitophagy and macroautophagy. Biochimica et Biophysica Acta -
Molecular Cell Research 1833, 205–2122013.
4. Dou, Z. et al. Autophagy mediates degradation of nuclear lamina. Nature 527, 105–109 (2015).
5. Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12,
1–222 (2016).
6. Koukourakis, M. I. et al. Autophagosome proteins LC3A, LC3B and LC3C have distinct subcellular distribution kinetics and
expression in cancer cell lines. PLoS ONE 10, https://doi.org/10.1371/journal.pone.0137675 (2015).
7. Park, Y.-E. et al. Autophagic degradation of nuclear components in mammalian cells. Autophagy 5, 795–804 (2009).
8. Carneiro, L. A. M. & Travassos, L. H. The Interplay between NLRs and Autophagy in Immunity and Inflammation. Front.
Immunol 4, https://doi.org/10.3389/fimmu.2013.00361 (2013).
9. Mizushima, N. Autophagy: Process and function. Genes and Development 21, 2861–2873 (2007).
10. Denais, C. M. et al. Nuclear envelope rupture and repair during cancer cell migration. Science 352, 353–358 (2016).
11. Woulfe, J. Nuclear bodies in neurodegenerative disease. Biochim. Biophys. Acta 1783, 2195–2206 (2008).
12. Gasset-Rosa, F. et al. Polyglutamine-Expanded Huntingtin Exacerbates Age-Related Disruption of Nuclear Integrity and
Nucleocytoplasmic Transport. Neuron 94, 48–57, e4 (2017).
13. Baron, O. et al. Stall in Canonical Autophagy-Lysosome Pathways Prompts Nucleophagy-Based Nuclear Breakdown in Neu-
rodegeneration. Curr. Biol. 27, 3626–3642, e6 (2017).
14. Mijaljica, D. & Devenish, R. J. Nucleophagy at a glance. J. Cell Sci. 126, 4325–4330 (2013).
15. Hayes, L. R. & Rothstein, J. D. C9ORF72-ALS/FTD: Transgenic Mice Make a Come-BAC. Neuron 90, 427–431 (2016).
16. Daigle, J. G. et al. Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity. Acta Neuropathol. 131,
605–620 (2016).
17. Buchser, W. et al. Assay Development Guidelines for Image-Based High Content Screening, High Content Analysis and High
Content Imaging. Assay Guidance Manual https://www.ncbi.nlm.nih.gov/books/NBK100913 (2012).
18. Lerch, J. K. & Buchser, W. Functional Genomics and High Content Screening in the Nervous System. Mol. Cell. Neurosci. 80,
159–160 (2017).
19. Schneider, C. A, Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9,
671–675 (2012).
20. Kamentsky, L. et al. Improved structure, function and compatibility for cellprofiler: Modular high-throughput image analysis
software. Bioinformatics 27, 1179–1180 (2011).
21. Greil, R., Anether, G., Johrer, K. & Tinhofer, I. Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders:
pathways, targets, and therapeutic tools. J. Leukoc. Biol. 74, 311–330 (2003).
22. Yang, M. et al. Poly-ADP-ribosylation of HMGB1 regulates TNFSF10/TRAIL resistance through autophagy. Autophagy 11,
214–224 (2015).
www.nature.com/sdata/
SCIENTIFIC DATA | 5:180116 | DOI: 10.1038/sdata.2018.116 7
23. Grespin, M. E. et al. Thyroid hormone receptor alpha1 follows a cooperative CRM1/calreticulin-mediated nuclear export
pathway. J. Biol. Chem. 283, 25576–25588 (2008).
24. Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344,
1396–1401 (2014).
25. Niles, W. D. & Coassin, P. J. Cyclic Olefin Polymers: Innovative Materials for High-Density Multiwell Plates. Assay Drug Dev
Technol 6, 577–590 (2008).
26. Lathey, D. C. Fluorescence Prediction through Computational Chemistry (Marshall University, 2005).
Data Citations
1. NCBI Gene Expression Omnibus GSE32474 (2011).
2. Kolla, L. et al. Figshare https://doi.org/10.6084/m9.figshare.c.3808666 (2018).
3. NCBI PubChem BioAssay AID 1640 (2009).
4. NCBI PubChem BioAssay AID 155 (2005).
Acknowledgements
The authors would like to thank Nazila Shafagati for helping with early planning stages of these
experiments. The NCI DTP provided the screening library. We would also like to thank Abigail Reft for
providing microscope support. Funding was provided by a collaborative EVMS-WM grant, William &
Mary Charles Center, Ferguson Funds, HHMI freshman research fellowship and W&M Honors funding.
Author Contributions
All authors took part in writing, reviewing and editing the manuscript. L.K. and D.S.H.: Planned screens,
executed experiments, imaged plates, analysed the data. Developed analysis pipeline provided in this
manuscript. General structure of the paper and writing of most sections of the manuscript, in addition to
review of most sections. D.P.R.: Major part of the early development of initial screening techniques and
microscopy as well as analysis and writing. S.A.B. A.A.M. E.E.C.: Executed the experiments, wrote small
sections of methods and introduction, reviewed manuscript. W.J.B.: Planned the manuscript and guided
the analysis and execution of experiments. Responsible for all the figure designs in the manuscript,
writing, and reviewing of the manuscript. This author has full access to all the data in the study and takes
responsibility for the integrity of the data and the accuracy of the data analysis.
Additional information
Supplementary information accompanies this paper at http://www.nature.com/sdata
Competing interests: The authors declare no competing interests.
How to cite this article: Kolla, L. et al. High content screen for identifying small-molecule LC3B-
localization modulators in a renal cancer cell line. Sci. Data 5:180116 doi: 10.1038/sdata.2018.1116
(2018).
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps
and institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 Interna-
tional License, which permits use, sharing, adaptation, distribution and reproduction in any
medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless indicated otherwise in
a credit line to the material. If material is not included in the article’s Creative Commons license and your
intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.
org/licenses/by/4.0/
The Creative Commons Public Domain Dedication waiver http://creativecommons.org/publicdomain/
zero/1.0/ applies to the metadata files made available in this article.
© The Author(s) 2018
www.nature.com/sdata/
SCIENTIFIC DATA | 5:180116 | DOI: 10.1038/sdata.2018.116 8
